191 related articles for article (PubMed ID: 14606586)
1. GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.
North PE; Mizeracki A; Mihm MC; Mrak RE
Clin Neuropathol; 2000; 19(3):131-7. PubMed ID: 14606586
[TBL] [Abstract][Full Text] [Related]
2. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
Rivera AL; Takei H; Zhai J; Shen SS; Ro JY; Powell SZ
Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
[TBL] [Abstract][Full Text] [Related]
3. Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas.
Brown DF; Dababo MA; Hladik CL; Eagan KP; White CL; Rushing EJ
Mod Pathol; 1998 Jan; 11(1):55-9. PubMed ID: 9556423
[TBL] [Abstract][Full Text] [Related]
4. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of spinal cord hemangioblastoma in von Hippel-Lindau disease].
Nakashima H; Tokunaga K; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
No Shinkei Geka; 1999 Jun; 27(6):533-40. PubMed ID: 10396736
[TBL] [Abstract][Full Text] [Related]
6. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM
Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
[TBL] [Abstract][Full Text] [Related]
8. Expression of brachyury in hemangioblastoma: potential use in differential diagnosis.
Barresi V; Vitarelli E; Branca G; Antonelli M; Giangaspero F; Barresi G
Am J Surg Pathol; 2012 Jul; 36(7):1052-7. PubMed ID: 22446946
[TBL] [Abstract][Full Text] [Related]
9. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
Park DM; Zhuang Z; Chen L; Szerlip N; Maric I; Li J; Sohn T; Kim SH; Lubensky IA; Vortmeyer AO; Rodgers GP; Oldfield EH; Lonser RR
PLoS Med; 2007 Feb; 4(2):e60. PubMed ID: 17298169
[TBL] [Abstract][Full Text] [Related]
10. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas.
Roy S; Chu A; Trojanowski JQ; Zhang PJ
Acta Neuropathol; 2005 May; 109(5):497-502. PubMed ID: 15864611
[TBL] [Abstract][Full Text] [Related]
11. Metastatic renal cell carcinoma to hemangioblastoma in von Hippel-Lindau disease.
Polydorides AD; Rosenblum MK; Edgar MA
Arch Pathol Lab Med; 2007 Apr; 131(4):641-5. PubMed ID: 17425399
[TBL] [Abstract][Full Text] [Related]
12. Metastasis of renal cell carcinoma to a haemangioblastoma of the medulla oblongata in von Hippel-Lindau syndrome.
Xiong J; Chu SG; Wang Y; Zhu JJ; Li C; Mao Y
J Clin Neurosci; 2010 Sep; 17(9):1213-5. PubMed ID: 20542433
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma.
Ingold B; Wild PJ; Nocito A; Amin MB; Storz M; Heppner FL; Moch H
Histopathology; 2008 May; 52(6):674-81. PubMed ID: 18393979
[TBL] [Abstract][Full Text] [Related]
14. Peripheral hemangioblastoma: clinicopathologic characterization in a series of 22 cases.
Doyle LA; Fletcher CD
Am J Surg Pathol; 2014 Jan; 38(1):119-27. PubMed ID: 24145646
[TBL] [Abstract][Full Text] [Related]
15. Von Hippel-Lindau disease: a case report.
Dave B; Patel V; Murthy AK; Khasgiwala R
Indian J Pathol Microbiol; 2003 Jul; 46(3):482-3. PubMed ID: 15025317
[TBL] [Abstract][Full Text] [Related]
16. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.
Hoang MP; Amirkhan RH
Am J Surg Pathol; 2003 Aug; 27(8):1152-6. PubMed ID: 12883249
[TBL] [Abstract][Full Text] [Related]
17. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.
Ozcan A; Shen SS; Zhai QJ; Truong LD
Am J Clin Pathol; 2007 Aug; 128(2):245-54. PubMed ID: 17638658
[TBL] [Abstract][Full Text] [Related]
18. Sporadic hemangioblastoma of the kidney in a 29-year-old man.
Wang CC; Wang SM; Liau JY
Int J Surg Pathol; 2012 Oct; 20(5):519-22. PubMed ID: 22271882
[TBL] [Abstract][Full Text] [Related]
19. Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier.
Cornford EM; Hyman S; Cornford ME; Landaw EM; Delgado-Escueta AV
J Cereb Blood Flow Metab; 1998 Jan; 18(1):26-42. PubMed ID: 9428303
[TBL] [Abstract][Full Text] [Related]
20. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease.
Vortmeyer AO; Frank S; Jeong SY; Yuan K; Ikejiri B; Lee YS; Bhowmick D; Lonser RR; Smith R; Rodgers G; Oldfield EH; Zhuang Z
Cancer Res; 2003 Nov; 63(21):7051-5. PubMed ID: 14612494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
